leisure time -WSS

leisure time

author：hotspot 2025-09-28 00:52:25 - browse：239

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Health officials lay out plans to cope with respiratory virus season

knowledge

WSS

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

How I helped Pfizer think through the ethics of Viagra

FDA advisory panel to debate high blood pressure devices

CDC recommends RSV monoclonal antibody for infants

Health officials lay out plans to cope with respiratory virus season

It costs an awful lot of money to give away a kidney

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

How to save PrEP access — and even expand it

CDC says it’s too soon to assess risk posed by Covid subvariant

Jerome Adams on the need for new antivirals for Covid

As obesity drug market grows, telehealth companies court payers

As demand for Covid shots wanes, Moderna seeks its next success

Intellia plays down concerns on accidental germline transmission

The cancer drug shortage isn’t new — and neither are the solutions

Physicians aren't 'burning out.' They're suffering from moral injury

Alkermes shareholders re

How I helped Pfizer think through the ethics of Viagra

hotspot

Group behind ProMed defends move to subscription

As obesity drug market grows, telehealth companies court payers

How to ethically and practically extend health care to all

Listen: Vivek Ramaswamy's star turn & leaky drug data

How the first Native Hawaiian psychiatrist helped diversify medicine

Heart disease in astronauts blamed on cosmic radiation

knowledge

knowledge

entertainment

entertainment